Tag:

Vacc-4x

Latest Headlines

Latest Headlines

Bionor's new HIV vaccine moves into clinical trials

May 31, 2012
Bionor's latest HIV vaccine, Vacc-C5, is ready to go into therapeutic clinical trials at Oslo University Hospital.

Nasal HIV vax safe, triggers immune response

May 17, 2012
The therapeutic HIV vaccine that the company nearly shelved in October 2011, Bionor's Vacc-4X, was safe given nasally to HIV-positive patients also on antiretrovirals.

Bionor HIV vaccine lowers viral load, ART need

September 14, 2011
Norwegian biotech Bionor Pharma has released results from a study of its therapeutic HIV vaccine, Vacc-4x. After initially planning to shelve the vaccine last October, the company is now plotting

Bionor stock skyrockets on unexpected HIV vax results

November 19, 2010
Norway's Bionor Pharma's stock almost quadrupled on the news that its HIV vaccine Vacc-4x unexpectedly reduced viral load. The trial was designed to test HIV-patients' ability to stay off

Related Tags

Press Releases

  • To Help Counter Record-High Levels of Cargo Theft, Chubb Adds Covert Shipment Tracking to Suite of Security Services
  • ViaCyte Appoints Dr. Paul Laikind Chief Executive Officer
  • The Myelin Repair Foundation Achieves Phase 1 Myelin Repair Clinical Trial
  • Biomet Announces Initial Closing of DePuy Trauma Acquisition
  • KCI Announces FDA 510(k) Clearance of V.A.C. Therapy for Management of Closed Surgical Incisions
  • More Press Releases

Featured Jobs

  • Post Doctorate - Cancer Immunology/Biology
    Immune Design - Seattle, WA
  • Diabetes Educator - Hattiesburg MS Job
    Novo Nordisk - Hattiesburg, MS, US
  • Sr. Director, Shared Services Americas Job
    Celgene Corporation - Berkeley Heights, NJ, US
  • Supervisor, QC Chemistry - 3rd Shift Job
    Celgene Corporation - Phoenix, AZ, US
  • Program Lead - Scientific Information Architecture & Search
    Merck - Kenilworth, NJ

Sponsored Links